The SASP generated by the combination of MEK and a CDK4/6 inhibitor induces the accumulation of CD8+ T cells and makes pancreatic ductal adenocarcinoma more sensitive to immune checkpoint blockade [26]. This evidence concerns the gene CD8A and pancreatic ductal adenocarcinoma.